November 2020
Leading Diagnostics Companies Join Forces to Establish the Access to Comprehensive Genomic Profiling Coalition (ACGP)
Seven leading diagnostics companies and laboratory service providers have formed the Access to Comprehensive Genomic Profiling Coalition (ACGP). The goal of the organization is to collectively advocate for appropriate broad U.S. health insurance coverage of comprehensive genomic profiling (CGP) for patients living with advanced cancer. The current members of ACGP are Exact Sciences, Foundation Medicine, Illumina, LabCorp, QIAGEN, Roche Diagnostics, and Thermo Fisher Scientific.

 

February 2020
Resolution Bioscience and LabCorp Will Collaborate to Commercialize the Resolution ctDx Lung™Liquid Biopsy Assay

June 2019
LabCorp and QIAGEN Announce New therascreen PIK3CA Mutation Analysis Companion Diagnostic For Metastatic Breast Cancer

May 2019
LabCorp Announces Availability of New QIAGEN therascreen FGFR mutation analysis companion diagnostic for Bladder Cancer

March 2019
Be The Match Partners with LabCorp to Help Grow Donor Registry

August 2018
The National Football League Alumni, Cancer Treatment Centers of America®, LabCorp® and Health Testing Centers Team Up to Offer Prostate Cancer Screenings in September

June 2018
LabCorp and Philips collaborate on digital pathology to enhance the efficiency of pathology diagnostics

June 2018
LabCorp and Unilabs Collaborate to Expand Global Reach of Precision Medicine Capabilities to Serve Patients, Physicians and Pharma

May 2018
LabCorp to Become a Preferred National Laboratory for Aetna

May 2018
UnitedHealthcare Establishes Long-term Strategic Partnership with LabCorp

February 2018
LabCorp Partners with Cheeriodicals through Community Service Campaign to Florida Hospital Memorial Medical Center and Halifax Health Medical Center

January 2018
LabCorp Named to FORTUNE Magazine's 2018 List of ‘World’s Most Admired Companies’

November 2017
LabCorp Announces New Expanded Use for PD-L1 Test with Bristol-Myers Squibb’s OPDIVO^®

September 2017
LabCorp Named Among “The World’s Most Innovative Companies” in Forbes’ 2017 Ranking

August 2017
OmniSeq and LabCorp Sign Exclusive Distribution Agreement and Series B Funding Commitment

May 2017
LabCorp Enhances VistaSeq Hereditary Cancer Test Portfolio with Addition of New Panels and New Genes That Can Be Assessed

June 2016
LabCorp Announces Launch of New Companion Diagnostic for Non-Small Cell Lung Cancer

January 2016
LabCorp and Cheeriodicals Spread Cheer to UNC Children’s